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Clinical Question
Which interventions improve medication 
adherence in patients with multiple medical 
conditions?
Evidence-Based Answer
Interventions that involve pharmacists to 
review, simplify, and monitor medication use 
significantly improve adherence in patients 
with multiple medical conditions. (Strength 
of Recommendation: B, based on heteroge-
neous randomized controlled trials [RCTs].) 
The effect of these interventions on patient-
oriented outcomes is not clear. There are no 
data on physician- or nurse-based interven-
tions for improving medication adherence.
Evidence Summary
A 2008 systematic review evaluating inter-
ventions to improve medication adherence 
found increased adherence in five of seven tri-
als.1 The authors could not perform a meta-
analysis because of the heterogeneous inter-
ventions and outcome measures. The first 
trial was an RCT of a pharmacist-based inter-
vention in seven European countries with 
2,454 patients (mean age = 74 years; mean 
number of medications per patient = 7).2 
Patients were presumed to have multiple 
medical conditions because of their age and 
the number of medications. Investigators 
supplied pharmacists in the intervention 
group with an instruction manual, and pro-
vided five training sessions on how to per-
form medication reviews, simplify regimens, 
create reminder charts, and educate patients. 
The pharmacists in the control group were 
not trained. Investigators measured adher-
ence using a patient self-report questionnaire. 
At 18 months, more patients in the interven-
tion group adhered to their prescribed medi-
cation regimen than in the control group 
(15.2 versus 12.2 percent; P = .03). There 
was no effect on quality-of-life scores or 
total health care costs. Forty-two percent 
of patients entering the trial were lost to 
follow-up.
An RCT from the United States evaluated 
a pharmacist-based intervention involving 
200 patients with hypertension and hyperlip-
idemia (mean age = 78 years; mean number 
of medications per patient = 9).3 Pharma-
cists provided patient education, performed 
follow-up to assess and support medication 
adherence, and dispensed medication in 
blister packs. After six months of pharma-
cist intervention, the remaining patients 
were randomized to continued intervention 
(n = 83) or usual care (n = 76) for another 
six months. Investigators measured adher-
ence using pill counts, and tracked blood 
pressure and low-density lipoprotein choles-
terol levels. Adherence rates increased from 
61.2 percent at baseline to 96.9 percent at six 
months (P < .001); however, at 12 months 
the intervention group continued to have 
high adherence, whereas adherence in the 
usual care group declined almost to baseline 
(95.5 versus 69.1 percent; P < .001). Systolic 
blood pressure was lower in the interven-
tion group than in the control group at 
12 months (124 versus 133 mm Hg; P = .001), 
although the diastolic blood pressure and 
low-density lipoprotein cholesterol levels 
were comparable. 
An RCT from Hong Kong evaluating 
patient adherence randomized 442 patients 
(mean age = 71 years; mean number of 
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medications per patient = 6) to receive 
usual care or a pharmacist-based interven-
tion that included medication consultations 
and reminder telephone calls.4 Investigators 
documented multiple medical conditions 
among the patients. Pharmacists made 10- to 
15-minute reminder calls to patients at the 
midpoint between scheduled physician vis-
its. At the end of the study, more patients 
in the intervention group reported adher-
ence than in the usual care group (81 versus 
58 percent; P = .001). Additionally, mortality 
rates were lower in the intervention group 
than in the control group (11 versus 17 per-
cent; relative risk of death = 0.59; 95% confi-
dence interval, 0.35 to 0.97; number needed 
to treat = 16 after adjustment for potential 
confounders). However, more patients in 
the intervention group were taking lipid-
lowering and antiplatelet medications, and 
cardiovascular events were the major cause 
of death in both groups.
A study from India randomized 90 patients 
in a 1:2 ratio to receive pharmacist counseling 
or usual care.5 Most patients were between 
40 and 60 years of age, and approximately 
90 percent had more than one medical con-
dition. Pharmacists at the patients’ own clin-
ics provided a single counseling session. One 
month later, patient adherence (as measured 
by pill count) was better in the intervention 
group than in the usual care group (92 versus 
85 percent; P value not given).
Two RCTs in the 2008 systematic review 
found no improvement in treatment adher-
ence with pharmacist intervention.1 The first 
was a six-month British study of 362 patients 
that compared usual care with pharma-
cist counseling in which pharmacists devel-
oped and revised medication plans with 
patients during follow-up visits. The second 
was a six-month U.S. study of 180 patients 
with diabetes mellitus and hyperlipidemia 
that compared usual care with pharmacist 
assessment of medication use by telephone.
Recommendations from Others
The Royal College of General Practitio-
ners recommends that physicians involve 
patients in decisions about their medications; 
understand patients’ knowledge, beliefs, 
and concerns about medications; provide 
medication-specific information; and assess 
adherence.6 To improve treatment adher-
ence in older patients, the University of 
Iowa Gerontological Nursing Interventions 
Research Center recommends using mem-
ory aids such as pill boxes and automatic 
dispensers, performing frequent physician 
review to reduce polypharmacy, and moni-
toring for changes in functional status that 
might impact adherence.7
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